Name
210: DISCOVER THE IMPACT OF GEMTESA: A Selective β3-Adrenergic Agonist for Effective OAB Treatment - Sponsored by Sumitomo Pharma America, Inc.
Date & Time
Saturday, March 2, 2024, 1:00 PM - 2:15 PM
Description
Sponsored by Sumitomo Pharma America, Inc.
Session Type
General